Clinical Outcomes and Cost-effectiveness Analysis of ShapeMatch Technology

NCT01483066 · clinicaltrials.gov ↗
PHASE4
Phase
TERMINATED
Status
38
Enrollment
OTHER
Sponsor class

Stopped FDA recall - Canadian system did voluntary suspension of study; Investigators subsequently decided to terminate the study

Conditions

Interventions

Sponsor

University of Alberta

Collaborators